Effect of vitamin D on blood pressure: a systematic review and meta-analysis

被引:282
作者
Witham, Miles D. [1 ]
Nadir, M. Adnan [2 ]
Struthers, Allan D. [2 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Sect Ageing & Hlth, Ctr Cardiovasc & Lung Biol,Div Med Sci, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol, Ctr Cardiovasc & Lung Biol,Div Med Sci, Dundee DD1 9SY, Scotland
关键词
blood pressure; hypertension; systematic review; vitamin D; LONG-TERM TREATMENT; RANDOMIZED CONTROLLED-TRIALS; CARDIOVASCULAR RISK-FACTORS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; D SUPPLEMENTATION; D ALPHACALCIDOL; 25-HYDROXYVITAMIN-D LEVELS; SERUM; 25-HYDROXYVITAMIN-D; CALCIUM SUPPLEMENTATION;
D O I
10.1097/HJH.0b013e32832f075b
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives Vitamin D insufficiency has been linked to hypertension and cardiovascular events in observational studies. It is unclear whether vitamin D supplementation can reduce blood pressure, and, if so, by how much. Methods We performed a systematic review and meta-analysis to examine whether vitamin D reduces blood pressure. Databases including MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied Health Literature and the Cochrane library were searched, supplemented by searches of grey literature, unpublished trials and references from included studies. Studies were assessed by two reviewers independently according to a prespecified protocol. Interventions included activated vitamin D, unactivated vitamin D2 and D3 and ultraviolet B radiation. Results Eleven randomized, controlled trials fulfilled the inclusion criteria. Studies were small and of variable methodological quality. Mean baseline blood pressure was more than 140/90 mmHg in eight studies. Meta-analysis of these eight studies showed a nonsignificant reduction in systolic blood pressure in the vitamin D group compared with placebo [-3.6mmHg, 95% confidence interval (CI) -8.0 to 0.7]. A small, statistically significant reduction was seen in diastolic blood pressure (-3.1mmHg, 95% CI -5.5 to -0.6). Subgroup analysis suggested that unactivated vitamin D produced a greater fall in systolic blood pressure than activated vitamin D (-6.2mmHg, 95% CI -12.32 to -0.04, vs. +0.7 mmHg, 95% CI -4.8 to 6.2). No reduction in blood pressure was seen in studies examining patients who were normotensive at baseline. Conclusion We found weak evidence to support a small effect of vitamin D on blood pressure in studies of hypertensive patients. J Hypertens 27: 1948-1954 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1948 / 1954
页数:7
相关论文
共 30 条
[11]  
Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
[12]  
LIND L, 1987, ACTA MED SCAND, V222, P423
[13]   REDUCTION OF BLOOD-PRESSURE DURING LONG-TERM TREATMENT WITH ACTIVE VITAMIN-D (ALPHACALCIDOL) IS DEPENDENT ON PLASMA-RENIN ACTIVITY AND CALCIUM STATUS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
LIND, L ;
WENGLE, B ;
WIDE, L ;
LJUNGHALL, S .
AMERICAN JOURNAL OF HYPERTENSION, 1989, 2 (01) :20-25
[14]   HYPERTENSION IN PRIMARY HYPERPARATHYROIDISM - REDUCTION OF BLOOD-PRESSURE BY LONG-TERM TREATMENT WITH VITAMIN-D (ALPHACALCIDOL) - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
LIND, L ;
WENGLE, B ;
WIDE, L ;
SORENSEN, OH ;
LJUNGHALL, S .
AMERICAN JOURNAL OF HYPERTENSION, 1988, 1 (04) :397-402
[15]  
LIND L, 1988, ACTA MED SCAND, V223, P211
[16]   NO MAJOR METABOLIC ALTERATIONS ACCOMPANY THE HYPOTENSIVE EFFECT OF ACTIVE VITAMIN-D [J].
LIND, L ;
WENGLE, B ;
LITHELL, H ;
LJUNGHALL, S .
UPSALA JOURNAL OF MEDICAL SCIENCES, 1991, 96 (03) :199-204
[17]   Effect of Calcium and Vitamin D Supplementation on Blood Pressure The Women's Health Initiative Randomized Trial [J].
Margolis, Karen L. ;
Ray, Roberta M. ;
Van Horn, Linda ;
Manson, Joann E. ;
Allison, Matthew A. ;
Black, Henry R. ;
Beresford, Shirley A. A. ;
Connelly, Stephanie A. ;
Curb, J. David ;
Grimm, Richard H., Jr. ;
Kotchen, Theodore A. ;
Kuller, Lewis H. ;
Wassertheil-Smoller, Sylvia ;
Thomson, Cynthia A. ;
Torner, James C. .
HYPERTENSION, 2008, 52 (05) :847-855
[18]   25-hydroxyvitamin D levels and the risk of mortality in the general population [J].
Melamed, Michal L. ;
Michos, Erin D. ;
Post, Wendy ;
Astor, Brad .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) :1629-1637
[19]   CARDIOVASCULAR RISK-FACTORS DURING ESTROGEN-NORETHINDRONE AND CHOLECALCIFEROL TREATMENT [J].
MYRUP, B ;
JENSEN, GF ;
MCNAIR, P .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (11) :2265-2268
[20]   Meta-analysis: Vitamin D compounds in chronic kidney disease [J].
Palmer, Suetonia C. ;
McGregor, David O. ;
Macaskill, Petra ;
Craig, Jonathan C. ;
Elder, Grahame J. ;
Strippoli, Giovanni F. M. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (12) :840-853